“…Another solution is to develop biomaterials, which incorporate a mechanism to control and sustain the release of GFs to aid SC migration, attachment, and rapid vascularization of the pulp space. These functionalized scaffolds could be injected into the root canal space and incorporate GFs such as bFGF, TGF-β1, PDGF, and VEGF [100–102], and other morphogens incorporated into the structure. Although seemingly a physiologically attractive solution, the use of exogenous GFs embedded in scaffolds is complicated by GF instability and short-half life, expense, safety, ethical issues, and the need for extensive clinical trials in various phases before approval.…”